Siga Technologies (SIGA) Share-based Compensation Growth (3y) (2013 - 2025)
Siga Technologies (SIGA) Share-based Compensation Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Siga Technologies | 210.16 Mn | 55.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 33.05% |
| Jun 30, 2025 | 46.15% |
| Mar 31, 2025 | 34.75% |
| Dec 31, 2024 | 30.64% |
| Sep 30, 2024 | 49.51% |
| Jun 30, 2024 | 25.88% |
| Mar 31, 2024 | 66.14% |
| Dec 31, 2023 | 5.31% |
| Sep 30, 2023 | 6.49% |
| Jun 30, 2023 | 30.65% |
| Mar 31, 2023 | 16.42% |
| Dec 31, 2022 | 21.26% |
| Sep 30, 2022 | 31.90% |
| Jun 30, 2022 | -10.27% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | -46.26% |
| Sep 30, 2021 | -47.64% |
| Jun 30, 2021 | 235.94% |
| Mar 31, 2021 | -9.03% |
| Dec 31, 2020 | 10.08% |